DOI:
10.1055/s-00000025
Hormone and Metabolic Research
LinksClose Window
References
de Filette J, Jansen Y, Schreuer M. et al.
Incidence of thyroid-related adverse events in melanoma patients treated with pembrolizumab.
J Clin Endocrinol Metab 2016;
101: 4431-4439
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.